STDs

This information sheet discusses the link between STDs and HIV. It explains how individuals with STDS have an increased susceptibility to HIV and individuals with HIV have increased infectiousness. The information sheet discusses how STD treatment can slow the spread of HIV and the implications for HIV and STD prevention programs. Information is provided for accessing the services of national health organizations.

This information sheet discusses the importance of bringing HIV and STD prevention programs into schools so adolescents can make healthy choices. It also provides information on CDC's Division of Adolescent and School Health (DASH). Topics include: schools play a critical role in HIV and STD prevention; prevention programs can reduce risk behaviors; DASH promotes effective prevention through schools; National HIV/AIDS Strategy; and Dash's programs are data driven and evidence based.

This information sheet discusses the importance of bringing HIV and STD prevention programs into schools so adolescents can make healthy choices. It also provides information on CDC's Division of Adolescent and School Health (DASH). Topics include: Effective HIV/STD Prevention Education Programs; Youth Asset-Development Programs; CDC's Ongoing Efforts to Identify and Implement Effective HIV/STD Prevention Programs for Youth.

This monograph is a curricular outline for examination of an STD patient. It explains the rationale and general clinical approach including epidemiological and medical goals of an STD intervention, taking a sexual history, risk indicators for STD, chief complaint and history of present illness, past medical and STD history, gynecologic history, HIV risk assessment, social history, clinical management, and patient education.

This video illustrates the interactions between TB and HIV, including their impact on the immune system, TB testing, and TB treatment.

This report summarizes laboratory and epidemiologic findings associated with reduced susceptibility to azithromycin. It notes that in August-October 2009, five of 55 N. gonorrhoeae isolates obtained from men with symptomatic urethritis tested at San Diego County’s main municipal STD clinic had high azithromycin minimum inhibitory concentrations (MIC)s.

This report discusses the sexually transmitted disease (STD), chlamydia, which is common among sexually active adolescents and young adults. It explains that although chlamydia may be asymptomatic, it can have serious consequences in females, including infertility; hence, the importance of chlamydia prevention. Screening females aged <25 years is ranked by the National Commission on Prevention Priorities as one of the 10 most beneficial and cost-effective prevention services, but it also is one of the most underutilized.

This pamphlet provides information about the STD chlamydia. It lists basic facts about the disease and discusses transmission, symptoms for men and women, testing, and treatment. The pamphlet explains that recent sex partners should be notified, as they would need to be tested for the disease and treated if infected. Chlamydia can be cured with antibiotic treatment, but an individual can be reinfected.

This report provides a summary of responses from a web-based survey of public health laboratories on volume and type of testing for STDs in the United States in 2007. The survey was conducted in 2008. Responses were received from 61.4 percent (94 of 153) participants. In 2007, 3,290,390 chlamydia tests and 3,157,827 gonorrhea tests were performed in the surveyed laboratories; 89.7 percent of chlamydia tests and 84.4 percent of gonorrhea tests were nucleic acid amplification tests. Over 90 percent of responders reported syphilis testing.

This report describes tests of an analysis of data from five laboratories that used reverse sequence screening during 2006-2010 to identify persons with possible untreated syphilis. Three sites served patient populations with low prevalence of syphilis, and two sites served patient population with high prevalence. The results indicated that among sera reactive on initial screening with an automatable treponemal enzyme and chemiluminescence immunoassays (EIA/CIA), 56.7 percent had a nonreactive rapid plasma regain (RPR) test.